The role of 3',4'-dihydroxyphenyl-?-valerolactone, the gut microbiota metabolite of (-)-epicatechin, in reducing insulin resistance (2020)

First Author: Helleur J

Abstract

No abstract provided

Bibliographic Information

Publication URI: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.841631

Type: Thesis